
In efforts to support emergency health needs in Ukraine, WHO have given 20 all-terrain ambulances able to function in even …

MGC Pharmaceuticals said a patent had been granted, protecting its unique system used to deliver a cannabis-derived drug being developed …

A UK trial has revealed that fourth-dose COVID-19 booster vaccines increase protection against the disease, particularly those aged over 70. …

Research at the National Institutes of Health (NIH) have identified distinct differences among the cells comprising a tissue in the …

Evofem has announced new data from the Phase III AMPOWER clinical trial of Phexxi (lactic acid, citric acid, and potassium …

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched an …

The FDA has imposed a partial clinical hold on BioCryst’s Factor D inhibitor, BCX9930. The clinical hold arrives around a …
The UK Health Security Agency has confirmed that a person in England has been diagnosed with the monkeypox virus.The patient …

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …

Shabir Hasham has served as Santhera’s Global Development Program Lead & Global Head Medical Affairs for the past three years, …
BIOCAPTIVA has announced the appointment of Alison Williamson as Chief Financial Officer, and member of the board.Alison has over 30 …

Richard Laxer joins Oxford Science Enterprises as an independent non-executive director. Richard is a veteran of GE Capital, serving the …

Dr Karen Mullen joins Boyds from GlaxoSmithKline, where, as Country Medical Director for UK and Ireland, she led and managed …

Over the last decade, our individual awareness and understanding of mental health has risen to unprecedented levels. Despite its pitfalls, …

A new report from WHO has highlighted the importance of effective IPC programmes, and shown that where good hand hygiene …
Open Orphan has been appointed by an unnamed existing “big pharma” client to host a Phase II field study of …

The FDA has limited the use of Johnson & Johnson’s coronavirus vaccine, to adults who cannot, or refuse to get, …

AstraZeneca’s treatment for heart disease has delivered positive high-level results from its Phase III DELIVER trial.Farxiga (dapagliflozin) is already approved …